Evidence map›Paper›PMID 25522382›Full record

ArticleThe international journal of neuropsychopharmacology2014

Chronic stimulation of the tone of endogenous anandamide reduces cue- and stress-induced relapse in rats.

Claudia Chauvet, Céline Nicolas, Nathalie Thiriet, Md Virginie Lardeux, Andrea Duranti, Marcello Solinas

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in The international journal of neuropsychopharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 29 citations in OpenAlex.

  1. FAAH and MAGL inhibition: Evolving approaches to treating substance use disorders.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Exercise as an adjunctive treatment for cannabis use disorder.The American journal of drug and alcohol abuse · 2016
    Review
  10. Review
  11. Statins Reduce the Risks of Relapse to Addiction in Rats.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2016
    Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Claudia ChauvetUniversity of Poitiers, France (Drs Chauvet, Nicolas, Thiriet, Lardeux, and Solinas); INSERM, Experimental and Clinical Neurosciences Laboratory, Poitiers, FRANCE (Drs Nicolas, Thiriet, Lardeux, and Solinas); Dipartimento di Scienze Biomolecolari, Università degli Studi di Urbino "Carlo Bo," Urbino, Italy (Dr Duranti).
Céline NicolasUniversity of Poitiers, France (Drs Chauvet, Nicolas, Thiriet, Lardeux, and Solinas); INSERM, Experimental and Clinical Neurosciences Laboratory, Poitiers, FRANCE (Drs Nicolas, Thiriet, Lardeux, and Solinas); Dipartimento di Scienze Biomolecolari, Università degli Studi di Urbino "Carlo Bo," Urbino, Italy (Dr Duranti).
Nathalie ThirietUniversity of Poitiers, France (Drs Chauvet, Nicolas, Thiriet, Lardeux, and Solinas); INSERM, Experimental and Clinical Neurosciences Laboratory, Poitiers, FRANCE (Drs Nicolas, Thiriet, Lardeux, and Solinas); Dipartimento di Scienze Biomolecolari, Università degli Studi di Urbino "Carlo Bo," Urbino, Italy (Dr Duranti).
Md Virginie LardeuxUniversity of Poitiers, France (Drs Chauvet, Nicolas, Thiriet, Lardeux, and Solinas); INSERM, Experimental and Clinical Neurosciences Laboratory, Poitiers, FRANCE (Drs Nicolas, Thiriet, Lardeux, and Solinas); Dipartimento di Scienze Biomolecolari, Università degli Studi di Urbino "Carlo Bo," Urbino, Italy (Dr Duranti).
Andrea DurantiUniversity of Poitiers, France (Drs Chauvet, Nicolas, Thiriet, Lardeux, and Solinas); INSERM, Experimental and Clinical Neurosciences Laboratory, Poitiers, FRANCE (Drs Nicolas, Thiriet, Lardeux, and Solinas); Dipartimento di Scienze Biomolecolari, Università degli Studi di Urbino "Carlo Bo," Urbino, Italy (Dr Duranti).
Marcello SolinasUniversity of Poitiers, France (Drs Chauvet, Nicolas, Thiriet, Lardeux, and Solinas); INSERM, Experimental and Clinical Neurosciences Laboratory, Poitiers, FRANCE (Drs Nicolas, Thiriet, Lardeux, and Solinas); Dipartimento di Scienze Biomolecolari, Università degli Studi di Urbino "Carlo Bo," Urbino, Italy (Dr Duranti). marcello.solinas@univ-poitiers.fr.
Université de Poitiers · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe endogenous cannabinoid system plays an important role in motivation, stress, and drug abuse. Pharmacologically, the endocannabinoid system can be stimulated by either agonists of CB1 receptors or inhibition of metabolic degradation of endogenous cannabinoids and consequent increases in their brain levels.

methodsHere, we investigated whether chronic administration during a period of withdrawal of the fatty acid amide hydrolase inhibitor URB597, which increases anandamide levels, would decrease the risks of relapse to cocaine seeking. Rats were allowed to self-administer cocaine and then they underwent forced withdrawal for 28 days, during which they were treated with URB597 or vehicle. One day after the last injection, we investigated cocaine seeking in one 6h extinction session and relapse triggered by re-exposure to drug-associated cues or a pharmacological stressor.

resultsWe found that administration of URB597 significantly decreases cocaine-seeking behavior and cue- and stress-induced relapse.

conclusionThese results suggest that stimulation of the endocannabinoid system could be helpful to prevent relapse to cocaine addiction.

Indexed as

CuesAmidohydrolasesAnimalsArachidonic AcidsBenzamidesCarbamatesCocaineCocaine-Related DisordersDisease Models, AnimalDopamine Uptake InhibitorsDrug-Seeking BehaviorEndocannabinoidsEnzyme InhibitorsFatty Acid Amide HydrolasesMalePolyunsaturated AlkamidesAmidohydrolasesanandamideArachidonic AcidsBenzamidesCarbamatesCocainecyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl esterDopamine Uptake InhibitorsEndocannabinoidsEnzyme InhibitorsFatty Acid Amide HydrolasesPolyunsaturated AlkamidesYohimbineabstinenceaddictionchronic treatmentendocannabinoidFAAHpsychostimulantsrelapsestress

Identifiers

PMID25522382
PMCPMC4368869
OpenAlexW2217130094

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.